Related Experiment Video
Updated: Mar 21, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Topical tacrolimus 0.03% for the treatment of ocular psoriasis
P Rodríguez-Ausín1, D Antolín-Garcia1, M Ruano Del Salado2
1Departamento de Oftalmología, Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, España.
Objective/Methods:
Cases are presented of 4 patients suffering from severe symptoms due to ocular psoriasis and who were treated with off-label 0.03% tacrolimus once a day.
Results/Conclusions:
All four patients had a mixed blepharitis and keratitis. Pseudopterygium and corneal opacities were present in three of them. All of them experienced an improvement of their itching and ocular surface. They all referred to a marked improvement of their quality of life in a follow-up period ranging from six months to two years. Therefore, topical tacrolimus could be considered an option in the treatment of ocular psoriasis.
Related Concept Videos
Ophthalmic Drug Delivery Systems
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Microbiome of the Eye

